Skip to main content

Anywhere in the World

Research is increasingly going global, a new report from Thompson Reuters says. The media and information company examined the science and innovation activity of the G20 member nations.

"The world is no longer bi-partite (Europe and North America) in terms of significant and even top-level science," the report notes. "It is now at least tri-partite (Europe, North America, and Asia) and perhaps more."

Based on an analysis of its Web of Science database, Thompson Reuters finds that most G20 nations have increased their output of scientific papers during the last decade, though some have ramped up their production faster than others, "resulting in shifting world shares."

It points out that the world share for China has increased to 14 percent in 2012 from 5.6 percent in 2003, while the US share dropped from 33 percent to 27.8 percent in the same time frame.

In addition, Thomson Reuters looked at how member nations fared on their Derwent World Patents Index. "The clearest thing to come out of the study," analyst David Pendlebury tells Wired, "is the shrinking in-country share of patents in 2012 despite the rise in overall number of patents. We're seeing that countries are more connected to each other than ever before."

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.